Showing results (531-540 of 863) with videos related to
Sort By:
Pageof 87
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Adenine nucleotide binding sites on beef heart F1 ATPase: photoaffinity labeling of beta-subunit Tyr-368 at a noncatalytic site and beta Tyr-345 at a catalytic siteR L Cross, D Cunningham, C G Miller, et al.American Journal of Public Health|September 29, 2007
Use of geographic information systems for planning HIV prevention interventions for high-risk youthsCatherine G Geanuracos, Shayna D Cunningham, George Weiss, et al.The Journal of Chemical Physics|August 10, 2017
Optical determination of the electronic coupling and intercalation geometry of thiazole orange homodimer in DNAPaul D Cunningham, William P Bricker, Sebastián A Díaz, et al.Oncology|December 15, 2010
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancerA F C Okines, U Asghar, D Cunningham, et al.European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Unknown primary carcinoma: randomised studies are needed to identify optimal treatments and their benefitsD C Farrugia, A R Norman, M C Nicolson, et al.Lancet (London, England)|April 19, 1997
BCL-2 antisense therapy in patients with non-Hodgkin lymphomaA Webb, D Cunningham, F Cotter, et al.British Journal of Cancer|October 1, 1993
The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphomaT Hickish, D Cunningham, K Colston, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancerM Findlay, A Hill, D Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphomaM Hill, D Cunningham, D MacVicar, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug schedulingJ Mansi, E Ellis, C Viner, et al.Pageof 87